The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.

The Beauty Health Company

In a report released yesterday, George Kelly from Roth MKM reiterated a Buy rating on Beauty Health, with a price target of $2.50. The company’s sh...

Roth MKM Keeps Their Buy Rating on Beauty Health (SKIN)

J.P. Morgan analyst Allen Gong maintained a Sell rating on Beauty Health yesterday. The company’s shares closed yesterday at $1.27. Gong covers the...

J.P. Morgan Sticks to Their Sell Rating for Beauty Health (SKIN)

Beauty Health Company (($SKIN)) has held its Q4 earnings call. Read on for the main highlights of the call. Beauty Health Company’s latest earnings...

Beauty Health Earnings Call Balances Margins And Growth

In a report released yesterday, Susan Anderson from Canaccord Genuity maintained a Hold rating on Beauty Health, with a price target of $1.50. Ande...

Market Cap	$178.50M	P/E Ratio	N/A
52W High	$2.69	52W Low	$0.76
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	60.3%	52W Position	8.5%
Overall Score	46	Value Score	60
Quality Score	42	Technical Score	36

EPS Current Est	$-0.18	EPS Next Est	$-0.12
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SKIN	$0.92	+5.00%	212.37K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	SKIN	$0.92	+5.0%	212.37K
3
4
5
6

SKIN

SKIN

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get The Beauty Health Company Data in Excel

Get The Beauty Health Company Data in Excel